BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31248946)

  • 1. GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study.
    Verri D; Pasciuto T; Epstein E; Fruscio R; Mascilini F; Moro F; Scambia G; Valentin L; Testa AC
    Int J Gynecol Cancer; 2019 Sep; 29(7):1216-1220. PubMed ID: 31248946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
    Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
    Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
    Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
    Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients.
    Qin J; Zhang S; Poon L; Pan Z; Luo J; Yu N; Wang L; Wu X; Cheng X; Xie X; Lu Y; Lu W
    Ultrasound Obstet Gynecol; 2021 May; 57(5):829-839. PubMed ID: 32385928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.
    Eysbouts YK; Ottevanger PB; Massuger LFAG; IntHout J; Short D; Harvey R; Kaur B; Sebire NJ; Sarwar N; Sweep FCGJ; Seckl MJ
    Ann Oncol; 2017 Aug; 28(8):1856-1861. PubMed ID: 28459944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone.
    Couder F; Massardier J; You B; Abbas F; Hajri T; Lotz JP; Schott AM; Golfier F
    Am J Obstet Gynecol; 2016 Jul; 215(1):80.e1-7. PubMed ID: 26829503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Doppler ultrasound useful for evaluating gestational trophoblastic disease?
    Lin LH; Bernardes LS; Hase EA; Fushida K; Francisco RP
    Clinics (Sao Paulo); 2015 Dec; 70(12):810-5. PubMed ID: 26735221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial.
    Cheng H; Zong L; Kong Y; Wang X; Gu Y; Cang W; Zhao J; Wan X; Yang J; Xiang Y
    Lancet Oncol; 2021 Nov; 22(11):1609-1617. PubMed ID: 34624252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients.
    Jiang F; Wan XR; Xu T; Feng FZ; Ren T; Yang JJ; Zhao J; Yang T; Xiang Y
    Gynecol Oncol; 2018 Jun; 149(3):539-544. PubMed ID: 29653688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia.
    Clark LH; Staley SA; Barber EL; Wysham WZ; Kim KH; Soper JT
    Am J Obstet Gynecol; 2016 Aug; 215(2):217.e1-5. PubMed ID: 26875944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis.
    Weng Y; Liu Y; Benjoed C; Wu X; Tang S; Li X; Xie X; Lu W
    J Zhejiang Univ Sci B; 2022 Mar; 23(3):218-229. PubMed ID: 35261217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
    Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
    Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial.
    Jiang F; Mao MY; Xiang Y; Lu X; Guan CL; Jiao LZ; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
    BMC Cancer; 2023 Aug; 23(1):784. PubMed ID: 37612621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?
    Frijstein MM; Lok CAR; Coulter J; van Trommel NE; Ten Kate-Booij MJ; Golfier F; Seckl MJ; Massuger LFAG
    Int J Gynecol Cancer; 2019 Jan; 29(1):108-112. PubMed ID: 30640691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of chest CT scan in gestational trophoblastic neoplasia with lung metastasis].
    Cheng Y; Ma FH; Wang XR; Le XN; Zhang GF; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):384-389. PubMed ID: 29961280
    [No Abstract]   [Full Text] [Related]  

  • 18. Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study.
    Harvey RA; Elias KM; Lim A; Bercow A; Short D; Horowitz NS; Berkowitz RS; Agarwal R; Seckl MJ
    Curr Probl Cancer; 2021 Feb; 45(1):100622. PubMed ID: 32800689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide.
    Braga A; Mora P; de Melo AC; Nogueira-Rodrigues A; Amim-Junior J; Rezende-Filho J; Seckl MJ
    World J Clin Oncol; 2019 Feb; 10(2):28-37. PubMed ID: 30815369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.